Article
 

Genetic Polymorphism of Cytochrome P450 4F2, Vitamin E Level and Histological Response in Adults and Children with Nonalcoholic Fatty Liver Disease Who Participated in PIVENS and TONIC Clinical Trials

Public Deposited

Contenu téléchargeable

Télécharger le fichier PDF
https://ir.library.oregonstate.edu/concern/articles/f7623f20h

Descriptions

Attribute NameValues
Creator
Abstract
  • Vitamin E improved liver histology in children and adults with NAFLD who participated in TONIC and PIVENS clinical trials, but with significant inter-individual variability in its efficacy. Cytochrome P450 4F2 (CYP4F2) is the major enzyme metabolizing Vit E, with two common genetic variants (V433M, rs2108622 and W12G, rs3093105) found to alter its activity. We investigated the relationship between CYP4F2 genotypes, α-tocopherol levels and histological improvement in these two trials. V433M and W12G variants were genotyped in TONIC (n = 155) and PIVENS (n = 213) DNA samples. The relationships between CYP4F2 genotypes, plasma α-tocopherol levels at baseline and weeks 48 (w48) and 96 (w96) and histological end points (overall improvement in liver histology and resolution of NASH) were investigated. As a result, the V433M genotype was significantly associated with baseline plasma α-tocopherol in the TONIC trial (p = 0.004), but not in PIVENS. Among those receiving Vit E treatment, CYP4F2 V433M genotype was associated with significantly decreased plasma α-tocopherol levels at w48 (p = 0.003 for PIVENS and p = 0.026 for TONIC) but not at w96. The w96 α-tocopherol level was significantly associated with resolution of NASH (p = 0.006) and overall histology improvement (p = 0.021)in the PIVENS, but not in the TONIC trial. There was no significant association between CYP4F2 genotypes and histological end points in either trial. Our study suggested the a moderate role of CYP4F2 polymorphisms in affecting the pharmacokinetics of Vit E as a therapeutic agent. In addition, there may be age-dependent relationship between CYP4F2 genetic variability and Vit E pharmacokinetics in NAFLD.
License
Resource Type
DOI
Date Available
Date Issued
Citation
  • Athinarayanan S, Wei R, Zhang M, Bai S, Traber MG, et al. (2014) Genetic Polymorphism of Cytochrome P450 4F2, Vitamin E Level and Histological Response in Adults and Children with Nonalcoholic Fatty Liver Disease Who Participated in PIVENS and TONIC Clinical Trials. PLoS ONE 9(4): e95366. doi:10.1371/journal.pone.0095366
Journal Title
Journal Volume
  • 9
Journal Issue/Number
  • 4
Déclaration de droits
Funding Statement (additional comments about funding)
  • This study was supported in part by the NIH/NIDDK grant (R21 DK090437) (WL) and the start-up fund (WL) by the Department of Medicinal Chemistryand Molecular Pharmacology, Purdue University. The NASH CRN Clinical Center at Indiana University is supported by the NIH grant U01DK061737, and the datacoordinating center at Johns Hopkins School of Public Health is supported by the NIH grant U01DK061730.
Publisher
Peer Reviewed
Language
Replaces

Des relations

Parents:

This work has no parents.

Articles

La vignette Titre Date de téléchargement Visibilité actes
file details TraberMaretPublicHealthHumanSciencesResponseAdultsChildren.pdf 07/25/2017 Public
file details TraberMaretPublicHealthHumanSciencesResponseAdultsChildren_SupportingInformation.zip 07/25/2017 Public